Triple combination of BRAF, MEK y EGFR inhibitors extends overall survival from 5.4 months with standard of care to 9 monthsCredit: VHIO Results presented today...
Credit: ETH Zurich / Daniel Razansky Scientists at ETH Zurich and the University of Zurich have used machine learning methods to improve optoacoustic imaging. This...
Credit: Peter Campochiaro In experiments with rats, pigs and monkeys, Johns Hopkins Medicine researchers have developed a way to deliver sight-saving gene therapy to the...
Credit: ATS Sept. 30, 2019--Women with asthma appear more likely to have lower levels of "free" (not attached to proteins) testosterone than women who do...
X-rays could be tuned to deliver a more effective punch that destroys cancer cells and not harm the bodyCredit: Illustration by Mindy Takamiya An element...
Credit: Phil Jones, Senior Photographer, Augusta University AUGUSTA, Ga. (Sept. 30 2019) - Insomnia is a driver of suicide, and particularly people with severe insomnia...
Scientists report in the Journal of Investigative Dermatology about a new highly reliable approach for overcoming the challenges of diagnosing cutaneous melanomaCredit: Image: Rodrigo Torres;...
Credit: Terada Laboratory, Waseda University A Waseda University-led research uncovered the molecular mechanism of how a particular cancer-causing oncogene could trigger an onset of acute...
Findings suggest all progressive, scarring lung diseases may share similar mechanismsCredit: National Jewish Health Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis,...
Funding to support development of a potential treatment for opioid withdrawalCredit: Stefanie Zingsheim/University of Sydney Kinoxis Therapeutics has been awarded a grant for a potential...
Credit: Intermountain Healthcare Determining how far patients with pulmonary disease can walk in six minutes has long been an effective clinical tool to help physicians...
Credit: The University of Sheffield Research shows that patients requiring emergency heart attack treatment also benefit from further intervention to reduce risk of future heart...
Phase III trial validates the benefit of veliparib for patients without a BRCA mutationCredit: MD Anderson Cancer Center Researchers from The University of Texas MD...
An international study shows that administering niraparib after chemotherapy reduces by nearly 40% the risk of relapse or death from this disease; The PI is...
In study, test proved able to detect and localize more than 20 types of cancer with a high degree of accuracy; Test detected methylation patterns...
